ESR1 and dermatitis: Tamoxifen, a non-steroidal estrogen receptor modulator, before and after type 1 sensitization of mice was demonstrated to inhibit allergic responses with a reduction of allergen-specific Ig levels and reduced allergen-induced dermatitis [91].